17 C
New York
Wednesday, September 27, 2023

Immunovant Inc. (IMVT) Is Not Likely To Be The Same Tomorrow

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for Immunovant Inc. (IMVT) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.17, or -0.75%, to $22.51. The Immunovant Inc. has recorded 7,760 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that Immunovant Reports Financial Results and Provides Corporate Updates for the Quarter Ended June 30, 2023.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Stocks Info

Immunovant Inc. is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $22.68 and fluctuated between $23.82 as its day high and $22.57 as its day low. The current market capitalization of Immunovant Inc. is $2.81B. A total of 0.97 million shares were traded on the day, compared to an average of 1.14M shares.

Insider Activity

Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, IMVT has seen 0 BUY and 6 SELL insider trades, representing the acquisition of 0 and the disposition of 113,110 shares. Over the last 12 months, there were 13 BUYs and 26 SELLs from insiders. Insiders purchased 1,310,687 shares during that period but sold 267,598.

In the most recent transaction, Salzmann Peter sold 56,774 shares of IMVT for 22.02 per share on Aug 30. After the transaction, the Chief Executive Officer now owns 969,965 company shares. In a previous transaction on Aug 24, Barnett Eva Renee sold 14,386 shares at 20.30 per share. IMVT shares that Chief Financial Officer owns now total 335,477.

Among the insiders who sold shares, Butchko Julia G. disposed of 12,333 shares on Aug 24 at a per-share price of $20.30. This resulted in the Chief Development Officer holding 416,260 shares of IMVT after the transaction. In another insider transaction, Macias William L. sold 12,333 shares at $20.30 per share on Aug 24. Company shares held by the Chief Medical Officer now total 337,392.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for IMVT in the last 3 months, the mean price target is $31.08 with high estimates of $34.00 and low estimates of $28.00. In terms of 52-week highs and lows, IMVT has a high of $25.13 and a low of $4.26.

As of this writing, IMVT has an earnings estimate of -$0.48 per share for the current quarter. EPS was calculated based on a consensus of 11 estimates, with a high estimate of -$0.34 per share and a lower estimate of -$0.55. The company reported an EPS of -$0.46 in the last quarter, which was -7.00% lower than expectations of -$0.43.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. IMVT’s latest balance sheet shows that the firm has $493.82M in Cash & Short Term Investments as of fiscal 2022. There were $2.36M in debt and $44.52M in liabilities at the time. Its Book Value Per Share was $2.30, while its Total Shareholder’s Equity was $469.82M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IMVT is Buy with a score of 4.69.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles